ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,757Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 939

$1.39M Total Retail Price of All Prescriptions

Rank: 13 out of 939

502 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 17,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 793 634 1 4
SIMVASTATIN 665 529 2 2
AMLODIPINE BESYLATE 660 564 3 6
POTASSIUM CHLORIDE 566 452 4 9
FUROSEMIDE 551 432 5 7
HYDROCODONE-ACETAMINOPHEN 538 270 S3 6 1
LISINOPRIL 513 388 7 3
METOPROLOL TARTRATE 501 407 8 10
GABAPENTIN 471 262 9 11
NAMENDA 461 436 10 49
OMEPRAZOLE 393 283 11 5
ATORVASTATIN CALCIUM 329 237 12 22
WARFARIN SODIUM 329 313 12 17
PRAVASTATIN SODIUM 326 289 14 13
METFORMIN HCL 311 252 15 8
MIRTAZAPINE 309 268 16 56
QUETIAPINE FUMARATE 301 208 17 69
DONEPEZIL HCL 295 292 18 30
ALENDRONATE SODIUM 281 208 19 40
CITALOPRAM HBR 263 207 20 15
TRAZODONE HCL 250 208 21 26
SERTRALINE HCL 237 153 22 24
CLONIDINE HCL 217 184 23 39
EXELON 214 190 24 151
TAMSULOSIN HCL 213 172 25 27
RISPERIDONE 204 146 26 82
CARVEDILOL 203 173 27 25
CYMBALTA 202 140 28 44
MELOXICAM 201 143 29 14
CRESTOR 201 139 29 34
VENLAFAXINE HCL ER 186 137 31 121
ALLOPURINOL 182 153 32 31
NEXIUM 173 84 33 18
FINASTERIDE 171 152 34 131
BACLOFEN 163 75 35 157
PHENYTOIN SODIUM EXTENDED 160 122 36 99
RAMIPRIL 146 120 37 91
PANTOPRAZOLE SODIUM 144 129 38 66
DIGOXIN 141 119 39 45
ESCITALOPRAM OXALATE 140 119 40 61
HALOPERIDOL 139 105 41 169
METHADONE HCL 136 48 S2 42 109
IPRATROPIUM-ALBUTEROL 134 128 43 178
DIVALPROEX SODIUM 131 98 44 95
ISOSORBIDE MONONITRATE ER 126 120 45 53
NOVOLOG 125 109 46 145
TRIAMTERENE-HCTZ 122 88 47 33
OLANZAPINE 121 104 48 135
METOCLOPRAMIDE HCL 118 65 49 119
FLUTICASONE PROPIONATE 117 88 50 43
DIVALPROEX SODIUM ER 115 37 51 146
ACTOS 113 87 52 141
CLOZAPINE 112 73 53 203
SEROQUEL 111 65 54 139
LYRICA 111 82 54 63
PROMETHAZINE HCL 111 46 R 54 68
ZOLPIDEM TARTRATE 110 50 57 20
ATENOLOL 109 78 58 19
TIZANIDINE HCL 108 41 59 81
CARBIDOPA-LEVODOPA 107 107 60 102
HYDROCHLOROTHIAZIDE 107 77 60 12
GLIPIZIDE ER 106 65 62 88
SUCRALFATE 106 82 62 96
LEVETIRACETAM 106 78 62 170
PREDNISONE 104 80 65 42
TRAMADOL HCL 104 71 65 16
CYCLOBENZAPRINE HCL 104 21 R 65 36
SPIRIVA 103 63 68 73
LEVOFLOXACIN 102 64 69 86
ROPINIROLE HCL 101 64 70 78
AMITIZA 100 89 71 301
GLIPIZIDE 99 39 72 52
OXCARBAZEPINE 99 85 72 227
METOPROLOL SUCCINATE 98 84 74 21
SINGULAIR 96 63 75 101
TRIAMTERENE-HYDROCHLOROTHIAZID 96 75 75 115
AZITHROMYCIN 95 68 77 32
CLOPIDOGREL 95 80 77 28
ABILIFY 91 60 79 156
CIPROFLOXACIN HCL 88 76 80 54
TRIAMCINOLONE ACETONIDE 86 62 81 150
ADVAIR DISKUS 86 52 81 60
POLYETHYLENE GLYCOL 3350 85 42 83 57
LOSARTAN POTASSIUM 85 62 83 29
AGGRENOX 84 83 85 153
DIOVAN 81 70 86 50
DOXYCYCLINE HYCLATE 78 62 87 84
NOVOLIN 70-30 77 54 88 211
BENZTROPINE MESYLATE 76 52 R 89 175
PATANOL 76 63 89 360
LANTUS 75 58 91 59
PROPRANOLOL HCL 75 56 91 117
PRIMIDONE 74 65 93 228
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 36 94 23
SPIRONOLACTONE 69 12 95 71
FAMOTIDINE 68 58 96 62
PLAVIX 67 56 97 48
LEXAPRO 66 64 98 201
FENOFIBRATE 65 26 99 83
LITHIUM CARBONATE 63 55 100 234
LEVEMIR 63 59 100 168
MUPIROCIN 62 50 102 185
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 43 102 64
CEPHALEXIN 60 48 104 77
VENLAFAXINE HCL 59 53 105 159
NYSTATIN 59 34 105 174
LAMOTRIGINE 58 24 107 187
JANUVIA 56 53 108 110
PAROXETINE HCL 55 38 109 70
MONTELUKAST SODIUM 54 31 110 172
PRAMIPEXOLE DIHYDROCHLORIDE 54 35 110 162
NYSTOP 54 33 110 289
FENTANYL 53 25 S2 113 104
NITROFURANTOIN 52 29 114 279
NITROFURANTOIN MONO-MACRO 52 42 114 180
FLUOXETINE HCL 50 30 116 47
CARAFATE 50 48 116 209
LACTULOSE 50 11 116 195
KETOCONAZOLE 50 42 116 229
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.